These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6367882)

  • 21. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of proton beam accelerated partial breast irradiation in breast cancer.
    Chang JH; Lee NK; Kim JY; Kim YJ; Moon SH; Kim TH; Kim JY; Kim DY; Cho KH; Shin KH
    Radiother Oncol; 2013 Aug; 108(2):209-14. PubMed ID: 23891102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
    Bartelink H; Horiot JC; Poortmans PM; Struikmans H; Van den Bogaert W; Fourquet A; Jager JJ; Hoogenraad WJ; Oei SB; Wárlám-Rodenhuis CC; Pierart M; Collette L
    J Clin Oncol; 2007 Aug; 25(22):3259-65. PubMed ID: 17577015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative radiation therapy: is it a standard now?
    Orecchia R; Leonardo MC
    Breast; 2011 Oct; 20 Suppl 3():S111-5. PubMed ID: 22015276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cancer of the breast: results and toxicity of locoregional irradiation after mastectomy].
    Cutuli B
    Cancer Radiother; 2000 Nov; 4 Suppl 1():167s-179s. PubMed ID: 11194957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant radiotherapy in breast cancer. Consideration of cost-benefits in relation to the CRC (Cancer Research Campaign) (King's/Cambridge) trial.
    Houghton J; Baum M
    Int J Technol Assess Health Care; 1989; 5(3):415-22. PubMed ID: 10313312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
    Gebski V; Lagleva M; Keech A; Simes J; Langlands AO
    J Natl Cancer Inst; 2006 Jan; 98(1):26-38. PubMed ID: 16391369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
    Poortmans PM; Collette L; Horiot JC; Van den Bogaert WF; Fourquet A; Kuten A; Noordijk EM; Hoogenraad W; Mirimanoff RO; Pierart M; Van Limbergen E; Bartelink H;
    Radiother Oncol; 2009 Jan; 90(1):80-5. PubMed ID: 18707785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of postoperative radiotherapy in node negative breast cancer patients with pT3-T4 disease.
    Aksu G; Kucucuk S; Fayda M; Saynak M; Baskaya S; Saip P; Ozturk N; Aslay I
    Eur J Surg Oncol; 2007 Apr; 33(3):285-93. PubMed ID: 17145158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
    Bantema-Joppe EJ; Vredeveld EJ; de Bock GH; Busz DM; Woltman-van Iersel M; Dolsma WV; van der Laan HP; Langendijk JA; Maduro JH
    Radiother Oncol; 2013 Aug; 108(2):269-72. PubMed ID: 24055289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Gruber G; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
    Bartelink H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Borger J; Jager J; Hoogenraad W; Collette L; Pierart M;
    N Engl J Med; 2001 Nov; 345(19):1378-87. PubMed ID: 11794170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient and anatomical selectivity in postoperative radiotherapy for early breast cancer: a British perspective.
    Ebbs SR; Yarnold JR
    Semin Surg Oncol; 1992; 8(3):167-71. PubMed ID: 1386682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2].
    Renner H; van Kampen M
    Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
    Barbieri V; Sanpaolo P; Genovesi D
    Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.